{"database": "openregs", "table": "dockets", "rows": [["FDA-2005-N-0516", "FDA", "Drug Approvals:  Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product", "Nonrulemaking", "2021-09-01T01:02:52Z", "0b0000648047abad"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-N-0516"], "units": {}, "query_ms": 131.88063696725294, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}